IperionX (NASDAQ:IPX) Trading 4.8% Higher - Here's What Happened

Key Points

• IperionX shares rose 4.8% to about $22.01 in midday trading, although volume was 58% below the stock’s average daily level.
• Analyst sentiment remains broadly positive: five analysts rate the stock Buy and one rates it Sell, producing a consensus “Moderate Buy” rating and an average price target of $53.33.
• Company insiders bought 663,720 shares worth approximately $2.38 million over the past quarter, while institutional investors and hedge funds collectively own 2.76% of the stock.

Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) traded up 4.8% during trading on Monday . The stock traded as high as $22.02 and last traded at $22.01. Approximately 112,583 shares were traded during mid-day trading, a decline of 58% from the average daily volume of 265,157 shares. The stock had previously closed at $21.01.

Analysts Set New Price Targets

Several brokerages have weighed in on IPX. BTIG Research lifted their price objective on shares of IperionX from $40.00 to $55.00 and gave the stock a "buy" rating in a research note on Friday, June 5th. Weiss Ratings restated a "sell (e+)" rating on shares of IperionX in a research report on Friday, July 17th. Finally, Roth Capital set a $53.00 target price on shares of IperionX in a report on Wednesday, August 5th. Five equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $53.33.

IperionX Trading Up 4.1%

The company has a current ratio of 4.03, a quick ratio of 4.00 and a debt-to-equity ratio of 0.03. The firm has a fifty day moving average price of $24.27 and a 200-day moving average price of $31.93.

Insider Transactions at IperionX

In other news, Chairman Todd Hannigan bought 300,000 shares of the company's stock in a transaction dated Monday, July 13th. The stock was bought at an average cost of $3.59 per share, for a total transaction of $1,077,000.00. Following the transaction, the chairman owned 26,633,334 shares of the company's stock, valued at $95,613,669.06. This represents a 1.14% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Anastasios Arima purchased 138,720 shares of the business's stock in a transaction dated Friday, July 10th. The shares were purchased at an average cost of $3.58 per share, with a total value of $496,617.60. Following the acquisition, the chief executive officer owned 12,455,502 shares in the company, valued at $44,590,697.16. This trade represents a 1.13% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 663,720 shares of company stock worth $2,379,118 over the last quarter.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC boosted its holdings in shares of IperionX by 40.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company's stock valued at $50,000 after purchasing an additional 483 shares in the last quarter. JPMorgan Chase & Co. acquired a new position in shares of IperionX during the 2nd quarter worth $66,000. State of Tennessee Department of Treasury acquired a new position in shares of IperionX during the 4th quarter worth $119,000. DV Equities LLC bought a new stake in shares of IperionX during the 4th quarter worth $178,000. Finally, Man Group plc bought a new stake in shares of IperionX during the 4th quarter worth $257,000. 2.76% of the stock is currently owned by institutional investors and hedge funds.

About IperionX

IperionX NASDAQ: IPX is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source